))
Mitch Sivilotti | OmniaBio
Manage episode 367155421 series 3429238
Content provided by Jim Wilson. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Jim Wilson or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
June 27, 2023 - Our guest today is Mitch Sivilotti, CEO of OmniaBio Inc. Mitch grew up in London, Ontario, and his journey has taken him to Quebec City, Los Angeles, Asia, Kingston, Toronto, and finally to Hamilton where he and his team are building what will be one of the next generation of cell and gene therapy manufacturing facilities in Canada. OmniaBio is a subsidiary of CCRM and it’s a contract development in and manufacturing organization (CDMO) that is producing gene-modified cells and viral vectors that are compliant with current GMP standards. OmniaBio is in the midst of building a 400,000 square-foot facility, which will be the largest CDMO exclusively manufacturing for cell and gene therapies in Canada, Mitch and the team are creating jobs and supporting global therapeutics developers who are advancing pioneering medicine that has the potential to cure many forms of cancer, cardiovascular diseases, Parkinson’s, and diabetes.
OmniaBio: OmniaBio.com
Get Your Tickets to The NGBI Summit: nextgreatbigideas.com
Lab Occupier: laboccupier.com
47 episodes
Share
